Taisho Pharmaceutical Holdings Co., Ltd.
TAISF · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $246 | $240 | $248 | $256 |
| Short-Term Investments | $20 | $20 | $20 | $0 |
| Receivables | $73 | $73 | $59 | $52 |
| Inventory | $64 | $63 | $58 | $53 |
| Other Curr. Assets | $14 | $13 | $18 | $14 |
| Total Curr. Assets | $417 | $410 | $403 | $376 |
| Property Plant & Equip (Net) | $149 | $149 | $143 | $141 |
| Goodwill | $135 | $137 | $129 | $128 |
| Intangibles | $113 | $115 | $111 | $110 |
| Long-Term Investments | $168 | $146 | $171 | $163 |
| Tax Assets | $8 | $7 | $8 | $7 |
| Other NC Assets | $17 | $37 | -$0 | $16 |
| Total NC Assets | $589 | $590 | $563 | $566 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,005 | $1,000 | $966 | $941 |
| Liabilities | – | – | – | – |
| Payables | $14 | $15 | $15 | $15 |
| Short-Term Debt | $0 | $0 | $0 | $2 |
| Tax Payable | $4 | $4 | $3 | $2 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $60 | $59 | $59 | $53 |
| Total Curr. Liab. | $81 | $80 | $80 | $74 |
| LT Debt | $0 | $0 | $0 | -$0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $41 | $41 | $37 | $33 |
| Other NC Liab. | $26 | $23 | $26 | $26 |
| Total NC Liab. | $67 | $64 | $62 | $58 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $148 | $144 | $142 | $132 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $723 | $0 |
| Common Stock | $30 | $30 | $30 | $30 |
| Retained Earnings | $716 | $717 | $714 | $714 |
| AOCI | $107 | $106 | $79 | $64 |
| Other Equity | -$21 | -$21 | -$744 | -$21 |
| Total Equity | $832 | $832 | $802 | $787 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $25 | $25 | $23 | $23 |
| Total Liab. & Tot. Equity | $1,005 | $1,000 | $966 | $941 |
| Net Debt | -$246 | -$240 | -$248 | -$255 |